Drug Innovation Ventures at Emory (DRIVE) and AbbVie have an ongoing research collaboration and licensing agreement to identify small molecules for the treatment of viral diseases.

DRIVE seeks to create strong partnerships to share expertise and develop new treatments for viral diseases of global concern. Although all partnerships are unique, DRIVE will identify molecules and partner companies can advance candidate antivirals in their fields of interest.